SARomics Biostructures provides premium services within protein crystallization, structure determination, protein NMR spectroscopy and computational chemistry. In addition, SARomics Biostructures’ integrated drug discovery services platform, which is run in close cooperation with Red Glead Discovery, combines key capabilities from a number of disciplines, leveraging state-of-the-art fragment-based hit generation techniques. These include our proprietary weak affinity chromatography (WAC™) fragment screening technology. SARomics has built a global reputation for its structural biology and drug discovery skills and is currently supporting clients in Asia, Europe, North America and Scandinavia to pursue their drug discovery objectives.
Redoxis is a preclinical service provider that performs tailor-made preclinical studies combining dedication, experience, and agility to provide reliable results to your project.
With core competence and experience in preclinical models for autoimmune and inflammatory conditions, Redoxis provides a wide range of in vivo and in vitro models, validated with standard reference therapies. Redoxis tailor-made high-quality services spanning across all aspects of the preclinical phase including MoA evaluation, ex vivo ranking, biomarker identification, in vivo efficacy and biomarker analyses.
By using Redoxis as your service provider you will get a dedicated and committed team with a core expertise and many years of experience in the field – for the benefit of your preclinical project!
Truly Labs is a CRO that provides a wide range of preclinical services in the area of early drug development. Our core disease areas are inflammatory and autoimmune diseases, respiratory, oncology and wound healing/wound infection with a primary focus on pharmacokinetics and pharmacodynamics. We offer a wide range of tailor-made in vitro and in vivo services, always with the aim to add the most possible value to the projects we support. Working together with Truly Labs you get access to a flexible team with extensive experience within the area of pre-clinical development of both small molecules and biologics.
Medicon Valley Inhalation Consortium
Red Glead Discovery is a member of Medicon Valley Inhalation Consortium, MVIC, a group of 25 companies in the Skåne-Copenhagen region that has world class expertise in the inhalation area. MVIC works to globally promote Medicon Valley as an international center of inhalation competence and to offer a comprehensive set of world class services in the inhalation field. The ambition of MVIC is to be the preferred partner of choice in the development of inhalation products.